Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
Cybersecurity, Privacy and Data Protection 2022 Year in Review
The year 2022 saw a groundswell of interest in privacy rights and related legislation. Five states enacted new laws or regulations aimed at protecting a …
NY DFS Issues Industry Letter on Health Outcomes and Disparities
New York health insurers are required to respond to a New York State Department of Financial Services (DFS) industry letter on health disparities and …
G20/B20: Can we avoid downside risks for the global economy?
Near enough is good enough: Full Federal Court of Australia revisits construction of “about” in patent claim
Penalties for breaches of Australian competition and consumer law set to increase
Investors Beware: Private Equity Firms Continue to Face Potential Liability Under the False Claims Act for Their Portfolio Companies’ Conduct
Two years ago, the U.S. Department of Justice announced a focus on enforcing the False Claims Act against private equity firms based on their portfolio …
Updates From ACI’s Advanced Forum on False Claims and Qui Tam Enforcement, June 22-23 in New York
Government, industry and outside counsel convened in New York June 22-23 at ACI’s Advanced Forum on False Claims and Qui Tam Enforcement to discuss …
First things first: Full Federal Court clarifies the law on patent term extensions
2022 Omnibus Spending Package Includes New Cybersecurity Incident Reporting Requirements for Critical Infrastructure Companies: How the Law May Affect Your Company
On March 15, 2022, President Joe Biden signed the Cyber Incident Reporting for Critical Infrastructure Act (the Act) into law as part of the $1.5 …
Will Trump-Appointed Justices Betray Their Stare Decisis Vow?
Litigation partner Michael J. Dell authored a RealClear Politics op-ed titled “Will Trump-Appointed Justices Betray Their Stare Decisis Vow?” …
Cyber-ransoms are on the rise: What do you need to know?
ACCC granted first interlocutory injunction to prevent merger in nearly 30 years
Key contacts
Alan Montgomery
Partner, Head of Life Sciences Sector, Chair of India Group, London
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London
Natalie Bryce
Partner, Brisbane